Devimistat T6157
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CPI-613, a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and _-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism. It has potential chemopreventive and antineoplastic activities, and has been used in tr
CAS nr:
95809-78-2
Purity:
98%
Molecular Weight:
388,59
SMILES:
OC(=O)CCCCC(CCSCc1ccccc1)SCc1ccccc1
Formula:
C22H28O2S2
Pathway:
Metabolism,Apoptosis,Metabolism
Target:
Mitochondrial Metabolism,Apoptosis,Dehydrogenase
